Nasdaq Scheduled Resumption in Moleculin Biotech, Inc.

NEW YORK, May 27, 2020 (GLOBE NEWSWIRE) — The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading in Moleculin Biotech, Inc. (Nasdaq: MBRX) is scheduled to resume on Thursday, May 28, 2020, at 7:00 a.m. Eastern Time.  Trading in the company’s stock was halted on May 4, 2020 at 9:25:06 Eastern Time.For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.NDAQONasdaq Media Contact:
Bianca Fata
[email protected]


Bay Street News

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search